HB
Hareshbhai Babubhai Gondaliya
About Hareshbhai Babubhai Gondaliya
Data last updated:
Hareshbhai Babubhai Gondaliya is a Director at Rextone Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Rextone Pharmaceuticals Private Limited reported revenue of ₹3.8 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rextone Pharmaceuticals Private Limited U74999GJ2021PTC125744 | Director | 21 Sep 2021 | 2021 | ₹3.8 Lakh (FY 2025) | Active |
Board colleagues of Hareshbhai Babubhai Gondaliya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jay Nalinbhai Hirpara | 09293422 | Rextone Pharmaceuticals Private Limited | Director |
| Vishalkumar Hirpara | 08758241 | Rextone Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hareshbhai Babubhai Gondaliya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hareshbhai Babubhai Gondaliya
Hareshbhai Babubhai Gondaliya currently holds 1 directorship: Rextone Pharmaceuticals Private Limited (Director, since 21 Sep 2021, revenue ₹3.8 Lakh (FY 2025)).
Hareshbhai Babubhai Gondaliya was first appointed on 21 Sep 2021 as Director at Rextone Pharmaceuticals Private Limited.
The current boards of Hareshbhai Babubhai Gondaliya's companies include Jay Nalinbhai Hirpara (Rextone Pharmaceuticals Private Limited), Vishalkumar Hirpara (Rextone Pharmaceuticals Private Limited).